*This webinar was recorded on Tuesday, August 22, 2023, and expires on August 22, 2024.*
About the Webinar
The opioid epidemic continues to have a devastating impact on countless lives. One significant concern is for patients who suddenly lose access to their opioid prescriber, medications for opioid use disorder (MOUD), or other controlled substances. In such cases, ensuring continuity of care becomes a critical factor in mitigating overdose risk. The Opioid Rapid Response Program (ORRP) is an interagency, coordinated federal effort to mitigate drug overdose risks among patients who abruptly lose access to a prescriber. Overseen by the U.S. Department of Health and Humans Services (HHS) Office of the Assistant Secretary of Health (OASH) and coordinated by the CDC and the Office of the Inspector General (HHS OIG), the ORRP supports the continuity of care of displaced patients who otherwise might face risks of withdrawal, overdose, or other harms. During this webinar, we will discuss how preparedness and state-coordinated response efforts between law enforcement, public health and state regulatory authorities can help mitigate overdose risk.
About the Speaker
Stephanie Rubel, MPH, leads the Overdose Preparedness and Response Team within the US Centers for Disease Control and Prevention (CDC), Division of Overdose Prevention. Stephanie has over 20 years of experience designing, managing and evaluating national public health programs, having worked as a consultant and federal government contractor supporting a wide range of public health program areas and largely focusing on enhancing multi-sector collaboration and public health emergency preparedness and response. In 2019 she joined CDC’s Center for Injury Prevention and Control to work on public health and public safety coordination in addressing the overdose crisis. Her team focuses on building state and local capacity to respond to overdose spikes, anomalies, and emergent threats. Since 2020, Stephanie has been building and directing the Opioid Rapid Response Program (ORRP), a federal interagency program designed to help mitigate risks among patients impacted by disrupted access to prescribed opioids or other prescribed controlled substances. She manages the program in coordination with the Office of Inspector General within the US Department of Health and Human Services and the Drug Enforcement Administration. Stephanie received a Master of Public Health in behavioral science and health education from Emory University in 2001.
About the Moderator
Jeffrey D. Carter, MD, became Chair of the FSMB in 2023 and has been a member of the FSMB Board of Directors since 2017. During his time on the board, he has held numerous committee appointments and served as Chair of the FSMB Workgroup on Diversity, Equityand Inclusion in Medical Regulation and Patient Care. Dr. Carter currently serves on the Missouri Board of Registration for the Healing Arts and was twice elected as its President. He isa graduate of Yale University School of Medicine, with postgraduate training in anesthesiology atWashington University School of Medicine. Dr. Carter has 25 years of practice experience as a board-certified anesthesiologist and is amember of Metro-West Anesthesia Group, Inc. in St. Louis. Dr. Carter’s contributions to clinical,administrative, and regulatory practice have been recognized by his peers yearly since 2007 with“The Best Doctors Award,” and he is the recipient of the St. Louis American Foundation’s “Excellencein Healthcare Award.”
Target Audience
This activity was designed specifically for physician and public members, as well as leadership staff of the state medical and osteopathic licensing boards, and others within the medical regulatory community.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
Accreditation Statement
The Federation of State Medical Boards is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statements
The Federation of State Medical Boards designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Federation of State Medical Boards certifies that non-physicians will receive an attendance certificate stating they participated in the activity that was designated for 1.0 AMA PRA Category 1 Credit™.
Disclosure Declaration
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
All faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. The following indicates the disclosure declaration information and the nature of any relationships with ineligible companies.
The speakers, course director, and planners at the Federation of State Medical Boards, have nothing to disclose.
System Requirements
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an internet browser capable of playing an HTML5 video.
Instructions for Participants and Obtaining CME Credit
There is no fee for this activity. To receive credit and receive their certificates, participants must view this CME activity in its entirety and complete the evaluation. The estimated time for completion of this activity is 1 hour.